Beranda › Flu › Virginia › Charlottesville
Uji klinis Flu di Charlottesville, VA
5 studi untuk Flu mencari peserta di lokasi sekitar Charlottesville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Menerima pesertaFase 3
- Research Site, Charlottesville
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Menerima pesertaFase 3Sukarelawan sehat diterima
- GSK Investigational Site, Charlottesville
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Menerima pesertaFase 1/2Sukarelawan sehat diterima
- Charlottesville Medical Research- Site Number : 8400016, Charlottesville
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
Menerima pesertaFase 1
- GSK Investigational Site, Charlottesville
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Menerima pesertaFase 2Sukarelawan sehat diterima
- Charlottesville Medical Research Center, LLC, Charlottesville
Uji klinis Flu di kota lain
- Atlanta, GA9 studi
- Washington, DC7 studi
- Chicago, IL5 studi
- Philadelphia, PA5 studi
- St. Louis, MO4 studi
- Houston, TX4 studi
- Durham, NC4 studi
- Baltimore, MD4 studi
- Hialeah, FL4 studi
- Seattle, WA4 studi
- Salt Lake City, UT4 studi
- Miami, FL3 studi
Studi lain di Charlottesville
- Kanker Paru Non-Sel Kecil21 studi
- Leukemia Mieloid Akut16 studi
- Kanker Prostat15 studi
- Kanker Metastatik13 studi
- Kanker Endometrium13 studi
- Kanker (semua jenis)13 studi
- Kanker Paru13 studi
- Gagal Jantung11 studi
- Kanker Ovarium10 studi
- Kanker Kolorektal10 studi
- Diabetes Tipe 19 studi
- Kanker Payudara9 studi
Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.